Cargando…
Comparing Medium-Term Clinical Outcomes following XEN® 45 and XEN® 63 Device Implantation
PURPOSE: To evaluate medium-term clinical outcomes with XEN® 45 or XEN® 63 Gel Stent (Allergan, Dublin, Ireland) for treatment of primary open angle glaucoma (POAG). Materials and Methods. Retrospective, descriptive, and observational study involving 40 patients implanted with a XEN® 45 Gel Stent an...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Hindawi
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7125472/ https://www.ncbi.nlm.nih.gov/pubmed/32280523 http://dx.doi.org/10.1155/2020/4796548 |